Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gliclazide 160mg/5ml oral suspension
0601021M0AAAJAJ
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 20mg/5ml oral suspension
0601021M0AAANAN
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 30mg/5ml oral suspension
0601021M0AAAPAP
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 50mg/5ml oral suspension
0601021M0AAAHAH
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Gliclazide 60mg/5ml oral suspension
0601021M0AAAGAG
|
Gliclazide | Gliclazide | Endocrine System | No data available |
|
Glidipion 15mg tablets
0601023B0BDACAA
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glidipion 30mg tablets
0601023B0BDAAAB
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glidipion 45mg tablets
0601023B0BDABAC
|
Glidipion | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glimepiride 2mg/5ml oral liquid
0601021A0AAAGAG
|
Glimepiride | Glimepiride | Endocrine System | No data available |
|
Glimepiride 6mg/5ml oral suspension
0601021A0AAAHAH
|
Glimepiride | Glimepiride | Endocrine System | No data available |
|
Glimil 80mg tablets
0601021M0BEAAAA
|
Glimil | Gliclazide | Endocrine System | No data available |
|
Gliquidone 30mg tablets
0601021R0AAAAAA
|
Gliquidone | Gliquidone | Endocrine System | No data available |
|
Glivec 100mg capsules
0801050AABBAAAA
|
Glivec | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Glivec 100mg tablets
0801050AABBACAC
|
Glivec | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Glivec 400mg tablets
0801050AABBABAB
|
Glivec | Imatinib mesilate | Malignant Disease and Immunosuppression | No data available |
|
Glizofar 15mg tablets (Arrow)
0601023B0BCADAA
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 15mg tablets (Teva)
0601023B0BCAAAA
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 30mg tablets (Arrow)
0601023B0BCAEAB
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 30mg tablets (Teva)
0601023B0BCABAB
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 45mg tablets (Arrow)
0601023B0BCAFAC
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Glizofar 45mg tablets (Teva)
0601023B0BCACAC
|
Glizofar | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Gloria Med class 1 (18-21mmHg) combined armsleeve with shoulder strap and mitten
21270002268
|
Gloria Med class 1 (18-21mmHg) combined armsleeve with shoulder strap and mitten | Lymphoedema Garments | Appliances | No data available |
|
Gloria Med class 2 (23-32mmHg) armsleeve with shoulder strap
21270002270
|
Gloria Med class 2 (23-32mmHg) armsleeve with shoulder strap | Lymphoedema Garments | Appliances | No data available |
|
Gloria Med class 2 (23-32mmHg) armsleeve with silicone grip top
21270002269
|
Gloria Med class 2 (23-32mmHg) armsleeve with silicone grip top | Lymphoedema Garments | Appliances | No data available |
|
Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max
21270002332
|
Gloria Med Comfort class 1 (18-21mmHg) below knee open toe max | Lymphoedema Garments | Appliances | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.